No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MBOT250117C5000
- 0.25
- 0.000.00%
15min DelayClose Dec 23 16:00 ET
0.00High0.00Low
0.25Open0.25Pre Close0 Volume19 Open Interest5.00Strike Price0.00Turnover634.83%IV441.24%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type0.4357Delta0.2453Gamma3.88Leverage Ratio-0.0129Theta0.0001Rho1.69Eff Leverage0.0010Vega
Intraday
- 5D
- Daily
News
Microbot Medical Stockholders Approve Key Proposals in 2024
MBOT Stock Gains Following FDA Submission of the LIBERTY System
Microbot Medical Announces FDA Submission for the Commercialization of the LIBERTY Endovascular Robotic System
Microbot Medical CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 With Additional Growth Expected
Earnings Week Ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and More